Summary Two hundred and thirteen lung tumours of primary site and 42 metastases were heterotransplanted into nude mice with an overall success rate of 44%. There were differences in success between the histological types. Squamous cell and adenocarcinoma had the highest success rate (51% and 43%, respectively) whereas large cell and small cell carcinoma had a lower success rate (38% for both). The average volume doubling times in the first passage in nude mice ranged from 8.2 in large cell carcinomas to 18.9 days in adenocarcinomas. In subsequent passages an increase in growth rate was found, the overall average doubling time falling from 14.5 days in the first passage to 7.1 days in the second passage. In a study with 171 non-small cell lung carcinomas (NSCLC), the growth data in nude mice were correlated with the clinical data of the corresponding patients. A relationship between the growth parameters in nude mice and prognosis of patients could not be found.
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During the past 3 years we have transplanted in the course of cooperative clinical studies 255 human lung tumours into nude mice. In this report we describe the incidence and rate of growth of these tumours in the nude mouse, as primary transplants and passaged tumours, and further we examined whether the growth characteristics of these tumours might be of clinical prognostic value. Comparison of a part of the presented data with other measurements and the clinical course will be published elsewhere.
Materials and methods
Nude mice Athymic nude NMRI-mice (own breeding or Zentralinstitut fur Versuchstierzucht, Hannover), female, 6-9 weeks old, were kept under standardized conventional conditions (Makrolon cages, 270C room temperature, 50% relative humidity, autoclaved bedding) in a separated room especially controlled against infections. An autoclaved special diet (altromin 1410, Altromin Spezialfutterwerke, D-4937 Lage) and acidified water (pH 2-3) were given ad libitum.
Patients and tumours
Two hundred and fifty five histologically verified lung tumours and their lymph node metastases from 213 patients were xenografted into nude mice. Table I . Also included in this report are take rate of lung tumours as already described (Mattern et al., 1981 (Table II) , however, these differences were not statistically significant. 
Discussion
Human solid tumours have now been heterotransplanted to the nude mouse (Fogh et al., 1980; Rofstad et al., 1982) or immune-deprived animals (Houghton & Taylor, 1978; Steel et al., 1983) in many laboratories. Our overall success rate of 44% with lung tumours agrees well with the experience of other workers (Sharkey et al., 1978; Shorthouse et al., 1980) . There were, however, differences in success between the histological types of heterotransplanted tumours. Shorthouse et al. (1980) have reported highest take rates for large cell and adenocarcinomas, whereas our success rate was highest with squamous cell carcinomas, however, the differences between the histological types are not significant. Gazdar et al. (1981) . reported successful heterotransplantation in 13/29 (45%) small cell carcinomas; our success rate was in the same range (6/16; 38% Fogh et al. (1980) demonstrated that metastases will grow more readily than will tumours of primary sites. This cannot be confirmed with our tumour material. Takes were higher for tumours of primary site (45%) than for lymph node metastases (36%) or recurrent tumours (40%).
The majority of lung carcinoma xenografts studied in the present work showed volume doubling times between 10 and 20 days (Table III) . Similar volume doubling times have been reported by other workers in nude mice (Rofstad et al., 1982) and in immune-deprived mice (Steel et al., 1983) . These volume doubling times are considerably shorter than those measured in man. Lung carcinomas have been found to have a wide range of growth rates with an average of -90 days (Straus et al., 1983) . Whatever the reasons may be for the short volume doubling times of the xenografts (e.g. reduced cell loss, difference in tumour volume, etc.), the rank within the different histological types remains the same (Straus et al., 1983;  Table III) . Large cell carcinoma which has been reported to grow faster than epidermoid or adenocarcinomas is also the tumour type which has the shortest doubling times in xenografted tumours in the first passage.
If tumours growing in the first passage in nude mice are successively transplanted, a further acceleration occurs between the first and second passages. In our study the overall average doubling time fell from 14.7 days to 7.1 days and remained fairly stable in the succeeding passages. This growth acceleration during the first few transplant generation has also been observed by other workers (Shimosato et al., 1976; Steel et al., 1983) . There appeared to be adaptation to growth of tumours in nude mice with succeeding passages.
There is evidence that growth of human tumours in nude mice and establishment of tumour lines is related to prognosis (Neely et al., 1983) . Our results with xenografted non-small cell lung carcinomas and the comparison with clinical data indicate that success in establishing growth is not dependent on histology, tumour size, lymph node involvement nor age of the patients. Only aneuploid tumours, as shown by flow cytometry, have a better success rate than diploid tumours. However, the difference is not significant. On the other hand, there exists a significant relationship between establishment of lines and histology, ploidy and proliferative pool.
In order to study the prognostic value of these growth parameters in nude mice, we divided patients into two groups depending on whether their tumours showed growth or not and correlated the two groups with the clinical data of the corresponding patients. There was a trend in survival between the two groups suggesting that tumours successfully grown in nude mice were more likely to behave aggressively in the patient; however, the difference was not significant.
In summary, the results show that despite certain significant data on growth of xenografts in nude mice, this model is of no prognostic value.
